5 min read

THERE’S BEEN A lot of talk of “revolutionary” drugs lately, thanks to GLP-1s like Ozempic that changed how obesity is treated. Now scientists are trying to replicate a similar groundbreaking feat in the world of sleep. Introducing AD109: a once-daily sleep apnea pill intended to eventually replace clunky CPAP machines.

The experimental drug has generated a lot of buzz. Scientists have been calling it the “ holy grail " treatment for sleep apnea, a sleep apnea “ star ,” among other things. It’s not completely unsubstantiated. The parent company, Apnimed, recently released Phase 3 clinical trial results showing some promising results across people from mild to severe sleep apnea. While not available yet in stores, the FDA has fast-tracked the application with a decision expected in early 2027.

Scientists involved with drug development are hopeful this nightly pill will eliminate most symptoms of sleep apnea, including loud snoring.…